BioOutsource To Open New Biosimilar Center of Excellence

Article

BioOutsource will open a new Biosimilar Center of Excellence in Scotland.

BioOutsource, a leader in biologics contract testing and biosimilar characterization for the biopharmaceutical industry, will open a new Biosimilar Center of Excellence in Glasgow. The new facility will double the company’s capacity for the analysis of biosimilar monoclonal antibodies.

The Biosimilar Center of Excellence is located on the West of Scotland Science Park in Glasgow, adjacent to the existing BioOutsource facility. The new operation will consist of approximately 40 laboratory and R&D scientists creating an estimated 20 new jobs.

Source: BioOutsource

Recent Videos
Behind the Headlines episode 6
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content